US2005121120A1PendingUtilityA1
Biomedical aid or implant
Est. expiryApr 13, 2019(expired)· nominal 20-yr term from priority
A61L 31/022A61L 27/047A61F 2310/00149A61F 2310/00107A61F 2310/00155A61F 2310/00113
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a stent manufactured from an alloy which contains at least 60% by weight, based on the weight of the alloy, of one or more metals selected from the group of gold, platinum, palladium and silver, silver being used only in combination with gold, platinum and/or palladium, and the alloy having a yield point of at least 200 N/mm 2 and an elongation at break of at least 8%.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . The method according to claim 9 , wherein the weight ratio of gold: palladium is between 3:1 and 0.5:1.
3 . The method according to claim 9 , wherein the weight ratio of silver: palladium is between 3:1 and 0.3:1.
4 . The method according to claim 9 , wherein the alloy contains at least 0.5% by weight, based on the weight of the alloy, of one or more metals selected from the group consisting of iridium, indium, gallium, tin, titanium, copper, zinc, and ruthenium.
5 . The method according to claim 9 , wherein the alloy has a yield point of at least 300 N/m 2 .
6 . The method according to claim 9 , wherein the alloy has an elongation at break of at least 20%.
7 . The method according to claim 9 , wherein the alloy further contains one or more of the metals selected from the group consisting of rhodium, rhenium, cerium, germanium, boron, iron, tantalum, nickel, cobalt, aluminum, niobium, zirconium, manganese, chromium, molybdenum and tungsten.
8 . The method according to claim 9 , wherein the alloy further contains one or more elements from the group consisting of silicon and carbon.
9 . A method of use of an alloy which contains at least 60% by weight, based on the weight of the alloy, of a combination of gold and palladium, or of a combination of silver and palladium, and the alloy having a yield point of at least 200 N/mm 2 and an elongation at break of at least 8%, comprising the step of manufacturing a biomedical aid or implant, comprising the alloy, for application in the human body at a site where the aid or implant is not exposed to the atmosphere.
10 . A method according to claim 9 , wherein the aid or implant is a stent, aneurysm clip, cardiac valve, occlusion coil, suture material, artificial joint or osteosynthesis material.
11 . A method of use of an alloy which contains at least 60% by weight, based on the weight of the alloy, of a combination of gold and palladium, or of a combination of silver and palladium, and the alloy having a yield point of at least 200 N/mm 2 and an elongation at break of at least 8%, comprising manufacturing a biomedical aid or implant having a structure comprising the alloy for increasing the MR compatibility of the biomedical aid or implant.
12 . The method of claim 11 , wherein the biomedical aid or implant has a higher MR compatibility than a second biomedical aid or implant which has the same structure as the biomedical aid or implant comprising the alloy but for comprising stainless steel 316 instead of the alloy.
13 . The method of claim 11 , wherein the biomedical aid or implant has a higher MR compatibility than a second biomedical aid or implant which has the same structure as the biomedical aid or implant comprising the alloy but for comprising nitinol instead of the alloy.
14 . The method of claim 11 , wherein the biomedical aid or implant has a higher MR compatibility than a second biomedical aid or implant which has the same structure as the biomedical aid or implant comprising the alloy but for comprising tantalum instead of the alloy.
15 . The method of claim 9 , wherein said manufacturing comprises forming a wire comprising the alloy.
16 . The method of claim 9 , wherein said manufacturing comprises forming a tube comprising the alloy.
17 . The method of claim 11 , wherein said manufacturing comprises forming a wire comprising the alloy.
18 . The method of claim 11 , wherein said manufacturing comprises forming a tube comprising the alloy.
19 . The method of claim 11 , wherein the weight ratio of gold: palladium is between 3:1 and 0.5:1.
20 . The method of claim 11 , wherein the weight ratio of silver: palladium is between 3:1 and 0.3:1.
21 . The method of claim 11 , wherein the alloy contains at least 0.5% by weight, based on the weight of the alloy, of one or more metals selected from the group consisting of iridium, indium, gallium, tin, titanium, copper, zinc, and ruthenium.Join the waitlist — get patent alerts
Track US2005121120A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.